Viusid/Alzer efficacy in the treatment of Parkinson’s disease associated fatigue

Authors

  • José Luis Giroud Benítez
  • María del Rosario Abreu Vázquez Biostatistician, Gastroenterology Institute, 25th St. No. 503 between H and I, Vedado, Havana, Cuba
  • Ovidio Gustavo Rodríguez Miranda MD, General Practitioner, Dr. Salvador Allende Hospital
  • Marisol Torres Monteagudo Neurologist, Dr. Salvador Allende Hospital
  • María Elena Tacoronte Morales Neurologist, Dr. Salvador Allende Hospital
  • Guillermo Toledo Sotomayor Neurologist, Dr. Salvador Allende Hospital
  • Yoandra García Sánchez Neurologist, Dr. Salvador Allende Hospital
  • Enerys Mendoza Tirado Neurologist, Dr. Salvador Allende Hospital
  • Víctor Frades García Neurologist, Dr. Salvador Allende Hospital
  • Félix Mariano Guevara Ferrer Neurologist, Dr. Salvador Allende Hospital
  • Jorge Luis Mato Oliva Neurologist, Dr. Salvador Allende Hospital
  • Estela Amarante Justiniani Neurologist, Dr. Salvador Allende Hospital
  • Fernando Martín Ordoño Neurologist, Dr. Salvador Allende Hospital
  • Milene Vázquez Martínez Neurologist, Dr. Salvador Allende Hospital
  • Mayra Carrasco García MD, General Practitioner, Dr. Salvador Allende Hospital

Keywords:

Parkinson’s disease, fatigue, Viusid, Alzer, nonmotor symptoms

Abstract

INTRODUCTION Fatigue is a very frequent symptom among patients with Parkinson’s disease for which there is no effective treatment. In clinical studies of patients with viral and liver diseases, fatigue improvement has been demonstrated with the use of Viusid and Alzer. METHODS. A randomized, double-blind and placebo controlled clinical trial was carried out in 100 patients, 50 in
each group, from October 2009 to May 2011. Group A or the study group, received combined Viusid and Alzer treatment and group B or the control group, placebo. RESULTS. At 3 months in the study group, only 2 showed fatigue (4%), which was maintained at six months and one year, with significant differences when compared to the control group. There was also improvement in fatigue severity, evaluated by PFS. CONCLUSIONS. The combined use of Viusid/Alzer nutritional supplements is effective in PD patient treatment, therefore it should be evaluated in studies with larger number of patients and a methodology that supports this indication.

Downloads

Download data is not yet available.

Downloads

Published

17-10-2023

How to Cite

Giroud Benítez, J. L., Abreu Vázquez, M. del R., Rodríguez Miranda, O. G., Torres Monteagudo, M., Tacoronte Morales, M. E., Toledo Sotomayor, G., … Carrasco García, M. (2023). Viusid/Alzer efficacy in the treatment of Parkinson’s disease associated fatigue. Belize Journal of Medicine, 1(3), 14–19. Retrieved from https://www.bjomed.org/index.php/bjm/article/view/44

Issue

Vol. 1 No. 3 (2012): July-December

Section

Original

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

BJM protects Copyright at all times. However, it gives up part of the rights by displaying a Creative Commons License 4.0 (cc-by-nc), which allows the use of the work to share (copy and redistribute the material in any support or format) and adapt (transform and built from the material) as long as exclusive mention of the publication in the journal as the primary source is made. Under no circumstances, the work can be commercialized.